DME Payer Mix: How Lenders Underwrite It
DME payer mix is one of the first things a lender examines when a durable medical equipment supplier applies for financing. Two suppliers with similar revenue can receive very different loan terms depending on how that revenue is split among Medicare, Medicare Advantage plans, Medicaid, commercial insurers and cash-paying customers. The same factors often show up again when a buyer values the business.
This article explains how lenders generally think about payer concentration and what suppliers can do to present their revenue clearly. Reimbursement and payer rules vary by state, program and plan, and nothing here is legal, billing or compliance advice.
What Payer Mix Means for a DME Supplier
Payer mix is the share of revenue that comes from each source of payment. For most DME suppliers, that includes some combination of:
- Traditional Medicare: fee schedules, documentation requirements and audit exposure
- Medicare Advantage plans: separate contracts, networks and prior authorization rules
- Medicaid: state-specific programs and managed care plans
- Commercial insurers: negotiated contracts that vary by plan
- Retail and cash sales: products sold directly to patients or facilities
Each source has its own payment timing, denial patterns and policy risk. Lenders want to know how much of the business depends on each one.
Why DME Payer Mix Matters to Lenders
A lender’s main question is whether the business can reliably generate the cash needed to repay a loan. DME payer mix affects that answer in several ways.
Concentration risk. If a large share of revenue comes from a single payer or plan, a change in that payer’s rates, coverage policy or network can affect the whole business. Lenders tend to view diversified revenue as more resilient.
Policy and reimbursement risk. Medicare fee schedules and programs such as competitive bidding can change reimbursement for entire product categories. Suppliers with heavy exposure to affected categories may face closer review. Our article on DME competitive bidding explains the upcoming changes.
Payment timing. Prior authorization requirements, claim review and plan-specific processes affect how long receivables take to collect. Slower collections mean more working capital is tied up.
Audit exposure. Government payers conduct payment reviews that can lead to payment holds or recoupments. Lenders look at audit history to judge how much revenue could be at risk.
How Lenders Analyze Payer Mix
Underwriters generally ask for revenue and receivables broken out by payer. Typical requests include:
- Revenue by payer for several years and the current year to date
- Accounts receivable aging by payer
- Denial and appeal history
- Copies or summaries of key commercial and Medicare Advantage contracts
- Revenue by product category, such as rentals, resupply and sales
- Any past audits, payment holds or repayment plans
Lenders may then adjust how they view earnings. For example, they may give less weight to revenue tied to a contract that is up for renewal, a product category facing reimbursement cuts or receivables that are aging beyond normal collection periods.
How Payer Mix Can Shape Loan Terms
Payer mix does not determine approval on its own, but it can influence structure. Depending on the lender and the business, it may affect:
- How much the lender is willing to advance
- Which receivables count toward a borrowing base on a line of credit
- Covenants tied to receivables, concentration or cash flow
- Reporting requirements during the life of the loan
- Whether an SBA-backed or conventional structure fits better
SBA 7(a) loans may be an option for some acquisitions and expansions, subject to program rules, the business, the borrower and lender review. Conventional loans follow each lender’s own underwriting standards. Every loan is subject to approval, and nothing here is a commitment to lend.
Suppliers relying on receivables-based financing should also understand how payer mix affects those arrangements. Our comparison of DME factoring vs a bank line of credit explains why some government receivables may be treated differently.
DME Payer Mix and Valuation
Buyers think about payer mix in much the same way. A supplier with diversified payers, recurring resupply revenue and a clean audit record may attract more interest than one that depends heavily on a single plan or a category facing cuts. Our article on DME company valuation covers the other factors buyers weigh.
Rental-heavy revenue adds another layer. Because many Medicare rentals end after a set period, lenders and buyers look at how soon that revenue will run off. Our article on how Medicare capped rental payments affect cash flow explains that dynamic.
How to Present Your DME Payer Mix to a Lender
Clear reporting can make a meaningful difference. Suppliers can prepare by:
- Producing revenue and receivables reports by payer from the billing system
- Reconciling those reports to financial statements
- Explaining any large shifts in payer mix and why they happened
- Documenting contract renewal dates for major payers
- Summarizing audit history and how any findings were resolved
- Outlining plans to diversify payers or product categories
An accountant and qualified billing professionals can help prepare these materials so they hold up under review.
Final Thoughts
DME payer mix tells lenders and buyers how resilient a supplier’s revenue really is. Concentration in one payer, exposure to reimbursement changes and slow-paying receivables can all affect loan structure and value. Suppliers that understand their mix, report it clearly and work toward diversification are often in a stronger position when they seek financing.
US Medical Funding helps durable medical equipment suppliers prepare for financing and present their business clearly to lenders. Learn more about our durable medical equipment financing options.
